Literature DB >> 29906488

Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.

Murli Mishra1, Hong Jiang2, Hedy A Chawsheen1, Matthieu Gerard3, Michel B Toledano4, Qiou Wei5.   

Abstract

Lung cancer is the leading cause of cancer death worldwide. Cigarette smoking and exposure to chemical carcinogens are among the risk factors of lung tumorigenesis. In this study, we found that cigarette smoke condensate and urethane significantly stimulated the expression of sulfiredoxin (Srx) at the transcript and protein levels in cultured normal lung epithelial cells, and such stimulation was mediated through the activation of nuclear related factor 2 (Nrf2). To study the role of Srx in lung cancer development in vivo, mice with Srx wildtype, heterozygous or knockout genotype were subjected to the same protocol of urethane treatment to induce lung tumors. By comparing tumor multiplicity and volume between groups of mice with different genotype, we found that Srx knockout mice had a significantly lower number and smaller size of lung tumors. Mechanistically, we demonstrated that loss of Srx led to a decrease of tumor cell proliferation as well as an increase of tumor cell apoptosis. These data suggest that Srx may have an oncogenic role that contributes to the development of lung cancer in smokers or urethane-exposed human subjects.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antioxidant; Cell growth and proliferation; Oxidative stress; Peroxiredoxins; Signal transduction

Mesh:

Substances:

Year:  2018        PMID: 29906488      PMCID: PMC6886468          DOI: 10.1016/j.canlet.2018.06.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  54 in total

1.  Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.

Authors:  Hojin Kim; Gong-Rak Lee; Jiwon Kim; Jin Young Baek; You-Jin Jo; Seong-Eun Hong; Sung Hoon Kim; Jiae Lee; Hye In Lee; Song-Kyu Park; Hwan Mook Kim; Hwa Jeong Lee; Tong-Shin Chang; Sue Goo Rhee; Ju-Seog Lee; Woojin Jeong
Journal:  Free Radic Biol Med       Date:  2015-12-23       Impact factor: 7.376

2.  Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.

Authors:  Hyun Ae Woo; Woojin Jeong; Tong-Shin Chang; Kwang Joo Park; Sung Jun Park; Jeong Soo Yang; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

Review 3.  Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.

Authors:  Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim
Journal:  Free Radic Biol Med       Date:  2005-03-24       Impact factor: 7.376

Review 4.  Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.

Authors:  W Todd Lowther; Alexina C Haynes
Journal:  Antioxid Redox Signal       Date:  2010-12-17       Impact factor: 8.401

Review 5.  SmokeHaz: Systematic Reviews and Meta-analyses of the Effects of Smoking on Respiratory Health.

Authors:  Leah Jayes; Patricia L Haslam; Christina G Gratziou; Pippa Powell; John Britton; Constantine Vardavas; Carlos Jimenez-Ruiz; Jo Leonardi-Bee
Journal:  Chest       Date:  2016-04-19       Impact factor: 9.410

6.  Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.

Authors:  Qiou Wei; Hong Jiang; Connie P Matthews; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

7.  Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke.

Authors:  Alberto Izzotti; Cristina Cartiglia; Mariagrazia Longobardi; Roumen M Balansky; Francesco D'Agostini; Ronald A Lubet; Silvio De Flora
Journal:  FASEB J       Date:  2004-08-02       Impact factor: 5.191

8.  Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.

Authors:  Qiou Wei; Hong Jiang; Alyson Baker; Lisa K Dodge; Matthieu Gerard; Matthew R Young; Michel B Toledano; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2013-02-07       Impact factor: 4.944

9.  At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice.

Authors:  M F Festing; A Yang; A M Malkinson
Journal:  Genet Res       Date:  1994-10       Impact factor: 1.588

Review 10.  Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.

Authors:  Jörn M Schattenberg; Mark J Czaja
Journal:  Redox Biol       Date:  2014-09-23       Impact factor: 11.799

View more
  5 in total

Review 1.  Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Authors:  Evan A Elko; Brian Cunniff; David J Seward; Shi Biao Chia; Reem Aboushousha; Cheryl van de Wetering; Jos van der Velden; Allison Manuel; Arti Shukla; Nicholas H Heintz; Vikas Anathy; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

Review 2.  Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer.

Authors:  Shivkanya Fuloria; Vetriselvan Subramaniyan; Sundram Karupiah; Usha Kumari; Kathiresan Sathasivam; Dhanalekshmi Unnikrishnan Meenakshi; Yuan Seng Wu; Mahendran Sekar; Nitin Chitranshi; Rishabha Malviya; Kalvatala Sudhakar; Sakshi Bajaj; Neeraj Kumar Fuloria
Journal:  Antioxidants (Basel)       Date:  2021-01-18

3.  Hyperoxidation of Peroxiredoxins and Effects on Physiology of Drosophila.

Authors:  Austin McGinnis; Vladimir I Klichko; William C Orr; Svetlana N Radyuk
Journal:  Antioxidants (Basel)       Date:  2021-04-15

4.  SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.

Authors:  Xiufang Lv; Hailing Yu; Qianqian Zhang; Quanyong Huang; Xiaopeng Hong; Ting Yu; Huimin Lan; Chaoming Mei; Wenkai Zhang; Hui Luo; Pengfei Pang; Hong Shan
Journal:  J Cell Mol Med       Date:  2020-08-03       Impact factor: 5.310

5.  Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.

Authors:  Pierre Dillard; Nicholas Casey; Sylvie Pollmann; Patrik Vernhoff; Gustav Gaudernack; Gunnar Kvalheim; Sébastien Wälchli; Else Marit Inderberg
Journal:  Oncoimmunology       Date:  2021-06-17       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.